Can GLP-1 drugs improve heart function during exercise in Obesity-Related heart failure?
Knowledge-focused
Not yet recruiting
This observational study follows people with obesity-related heart failure to see how their heart performs during exercise, using stress echocardiography. It observes those who are taking GLP-1/GIP receptor agonists (like semaglutide or tirzepatide) as part of their routine care,…
Sponsor: Miedziowe Centrum Zdrowia SA • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC